Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

PUBLICATION DATE

25 results
Display

Molecular Screening and Analysis of Ligand Proteins Association with Unique - SH3 Domain of c - Yes

Kwak SJ, Seong YS

  • KMID: 2329131
  • J Korean Cancer Assoc.
  • 1998 Apr;30(2):394-401.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Irradiation alone in Stage IB , IIA and IIB Cervix Cancer: 2 Correlation between Treatment Factors and Pelvic Tumor Control

Ahn SJ, Chung WK, Nah BS, Nam TK, Choi HS, Byun JS

  • KMID: 2329123
  • J Korean Cancer Assoc.
  • 1998 Apr;30(2):321-328.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Early Gastric Cancer Associated with Small Cell Lung Cancer

Park MK, Kwon TH, Park JH, Yun SY, Choi SH, Son SP

  • KMID: 2329133
  • J Korean Cancer Assoc.
  • 1998 Apr;30(2):414-420.
The incidence of multiple primary cancers is low than that of single primary cancer. In gastric cancer, incidence of occurrence of multiple primary cancer is 3 to 11.3%. Because stomach...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Chemopotentiation of Fresh Acute Myelogenous Leukemic Cells by Recombinant Human Granulocyte - Macrophage Colony - Stimulating Factor ( GM-CSF ) and Methotrexate

Kim HT, Ahn JS, Kim ES, Bang YJ, Kim BK, Kim NK

  • KMID: 2329127
  • J Korean Cancer Assoc.
  • 1998 Apr;30(2):357-369.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Restrospective Cohort Study of Survival and Prognostie Factors in Patients with Terminal Cancer

Yun YH, Heo DS, Bae JM, Im SA, Yoo TW, Huh BY, Kim NK

  • KMID: 2329130
  • J Korean Cancer Assoc.
  • 1998 Apr;30(2):384-393.
PURPOSE: Cancer has become the major cause of deaths in Korea. Planning care for patients with terminal cancer is difticult. The prediction of length and prognostic factors of survival in...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Utilization of Alternative Therapies in Cancer Patients

Lee KS, Ahn HS, Hwang LI, Lee YS, Koo BH

  • KMID: 2329110
  • J Korean Cancer Assoc.
  • 1998 Apr;30(2):203-213.
PURPOSE: To determine patient's use of alternative cancer therapies, as well as the characteristics of the patients who used these therapies, descriptive study was conducted at the one college hospital...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Comparative Study between Peripharal Venous Blood and Draining Venous Blood CEA Levels in Colorectal Cancer

Lee KB, Lee ES, Kim YC

  • KMID: 2329121
  • J Korean Cancer Assoc.
  • 1998 Apr;30(2):306-312.
PURPOSE: In colon cancer, CEA(carcinoembryonic antigen) has become one of the useful tools for the management of patients because the antigen has been found to be useful as a monitor...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Breast Cancer of 35 Years Old or Less

Kang HS, Yang HK, Noh DY, Yong YK, Kim SJ, Oh SK, Choe KJ, Kim JP

  • KMID: 2329116
  • J Korean Cancer Assoc.
  • 1998 Apr;30(2):262-271.
PURPOSE: The age of onset of Korean breast carcinoma is younger than that in western countries by some 10 years, thus the criteria of young age in manuscript from western...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Primary Leiomyosarcoma of the Breast

Yang JH, Lee HK, Nam SJ, Kim GR

  • KMID: 2329134
  • J Korean Cancer Assoc.
  • 1998 Apr;30(2):421-424.
We describe a 42-year-old woman with a primary leiomyosarcoma of the breast. It is an extremely rare tumor, with only about 16 cases reported. Usually it is presented with palpable...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
FPL ( 5-Fluorouracil / Cisplatin / Levamisole ) Combination Chemotherapy for Metastatic or Recurrent Gastric Carcinoma

Ko BS, Lee KH, Choe KH, Park SM, Youn SJ, Kim ST

  • KMID: 2329117
  • J Korean Cancer Assoc.
  • 1998 Apr;30(2):272-277.
PURPOSE: FP(5-FU, Cisplatin) combination is one of the most active regimen for the advanced gastric cancer with a response rate of 50~60%. In spite of this high response rate, there...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Studies on Relationship between Expression of ras , p53 , c-erbB2 and p53 and Phenotypic Expression Using Mucin Histochemistry in Human Gastric Carcinomas

Kim KK, Kim SW, Ko YB, Lee JH, Kim WG, Cho SG, Kim JM, Joo YC, Hwang TS, Yang HK, Kim JP

  • KMID: 2329119
  • J Korean Cancer Assoc.
  • 1998 Apr;30(2):288-299.
PURPOSE: Recent studies have shown that the expression of mucin is organ- and cell-type specific and it is increasingly possible that its change could result from oncogene activation.To evaluate histogenesis...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Combination Chemotherapy with Cisplatin , Etoposide , and Ifosfamide ( PIE ) in the Advanced Non - Small Cell Lung Cancer

Shin SW, Kim BS, Shin JJ, Kim YH, Kang KH, Choi YH, Kim KT, Kim JS

  • KMID: 2329112
  • J Korean Cancer Assoc.
  • 1998 Apr;30(2):225-230.
PURPOSE: Combination chemotherapy with cisplatin and etoposide have been considered as one of the chemotherpy regimen for non small cell lung cacer(NSCLC) with the response rate of 20~40%. Ifosfamide is...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Semi - quantitative Comparison of Terminal Restriction Fragment Length and Telomerase in Breast Cancer for Biotherapy

Rha SY, Park KH, Kim TS, Kim JH, Roh JK, Min JS, Lee KS, Kim BS, Chung HC

  • KMID: 2329113
  • J Korean Cancer Assoc.
  • 1998 Apr;30(2):231-241.
PURPOSE: We determined the clinical significance of telomerase activity and telomere length in breast cancer patients and also developed the measuring system of telomerase activity change with RNAse A pre-treatment....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Combined Chemoradiation of Advanced Pancreatic Cancer

Jang JY, Kang KM, Kim IA, Choi IB, Lee JH, Kim EK, Kim SN, Sun HS, Chung KW, Choi MK, Han JY, Mun HL

  • KMID: 2329120
  • J Korean Cancer Assoc.
  • 1998 Apr;30(2):300-305.
PURPOSE: This study was designed to evaluate the survival rate and prognostic factor of patients with advanced pancreatic cancer who received chemoirradiation. MATERIAL AND METHODS: From March 1993 to November...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Germline Mutation of BRCA2 Gene in Korean Breast / Ovarian Cancer Families

Won YJ, Oh JH, Kim JH, Noh DY, Choe KJ, Kang SB, Kim LS, Ro MS, Paik NS, Yang DH, Oh SM, Lee SN, Kim KK, Park JG

  • KMID: 2329114
  • J Korean Cancer Assoc.
  • 1998 Apr;30(2):242-252.
PURPOSE: Recent discovery of BRCA1 and BRCA2 genes has made it possible to perform presymptomatic diagnosis in hereditary breast/ovarian cancer families. We have previously reported germline mutations of the BRCA1...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Urinary Nuclear Matrix Protein ( NMP 22 ) in the Detection of Transitional Cell Carcinoma of the Bladder

Ryu SB, Oh BR, Suh SP, Kwon DD, Ryu JW, Park YI

  • KMID: 2329129
  • J Korean Cancer Assoc.
  • 1998 Apr;30(2):378-383.
PURPOSE: The detection of bladder cancers by noninvasive techniques remains an unsolved problem. We evaluate the availability of an immunoassay for urinary nuclear matrix protein, NMP 22, as an indicator...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Application of Mitochondrial Morphology for Diagnosis of Steroidogenous Cell Origin Tumor: on the basis of the primary and the metastatic ovarian tumors

Lim SC, Seo JH

  • KMID: 2329132
  • J Korean Cancer Assoc.
  • 1998 Apr;30(2):402-413.
PURPOSE: The purpose of this study is to evaluate the diagnostic availability of the morphology of mitochondria to identify the nature or the origin of neoplasms. MATRIALS AND METHODS: We...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Inquiry about Management of Non-Small Cell Lung Cancer

Park JY, Kim JS, Kam S, Chae SC, Won JH, Kim CH, Kim JC, Jun SH, Park IK, Jung TH

  • KMID: 2329111
  • J Korean Cancer Assoc.
  • 1998 Apr;30(2):214-224.
PURPOSE: In recent years there has been a considerable increase in the use of chemotherapy as an adjuvant to surgery, radical radiotherapy and in addition to best supportive care. However,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Results of CHOP-Bleo / CMED Alternating Chemotherapy for Aggressive Non - Hodgkin's Lymphoma

Kim SJ, Choi IK, Oh SC, Seo JH, Kim BS, Shin SW, Kim YH, Kim JS

  • KMID: 2329126
  • J Korean Cancer Assoc.
  • 1998 Apr;30(2):350-356.
PURPOSE: To assess the efficacy and toxicity of a new protocol that consists of CHOP- Bleo alternated with a new regimen of Cyclophosphamide, methotrexate, etoposide, and dexamethasone(CMED) for aggressive Non-Hodgkin's...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Prognostic Significance of the p53 Overexpession on Complete Response and Survival in Preoperative Chemoradiotherapy Treated Squamous Cell Esophageal Carcinoma

Kim SB, Kim SH, Jung HY, Lee HK, Kang GH, Kim JH, Song HY, Park SI, Kim DK, Kim HR, Hong WS, Lee JH, Kim SW, Sun CW, Lee KH, Lee JS, Kim WK, Min YI

  • KMID: 2329118
  • J Korean Cancer Assoc.
  • 1998 Apr;30(2):278-287.
PURPOSE: To determine the frequency of p53 overexpression and to analyse the relationship between p53 overexpression and complete response rate, survival in locoregionl squamous cell esophageal cancers treated with preoperative...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr